Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Equity Ratio (2016 - 2026)

Mimedx's Equity Ratio history spans 17 years, with the latest figure at 0.79 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 4.96% to 0.79 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.79, a 4.96% increase, with the full-year FY2025 number at 0.75, up 2.32% from a year prior.
  • Equity Ratio hit 0.79 in Q1 2026 for Mimedx, up from 0.75 in the prior quarter.
  • Over the last five years, Equity Ratio for MDXG hit a ceiling of 0.79 in Q1 2026 and a floor of 0.11 in Q3 2022.
  • Historically, Equity Ratio has averaged 0.4 across 5 years, with a median of 0.7 in 2024.
  • Biggest five-year swings in Equity Ratio: tumbled 24147.84% in 2022 and later soared 10447.82% in 2024.
  • Tracing MDXG's Equity Ratio over 5 years: stood at 0.1 in 2022, then skyrocketed by 668.98% to 0.6 in 2023, then increased by 22.56% to 0.73 in 2024, then grew by 2.32% to 0.75 in 2025, then grew by 5.12% to 0.79 in 2026.
  • Business Quant data shows Equity Ratio for MDXG at 0.79 in Q1 2026, 0.75 in Q4 2025, and 0.75 in Q3 2025.